Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Metastasis02:30

Metastasis

6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social determinants of health and epigenetic clocks: a systematic review and meta-analysis of 140 studies.

Nature human behaviour·2026
Same author

Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026
Same author

Efficacy of cabozantinib and sunitinib for the treatment of intermediate/poor risk renal cell carcinoma based upon UK real-world data.

ESMO real world data and digital oncology·2026
Same author

Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC).

ESMO real world data and digital oncology·2026
Same author

ERRATUM: Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.

Endocrine-related cancer·2025
Same author

The Royal College of Radiologists' Re-Audit of UK Prostate Brachytherapy Delivery.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Related Experiment Video

Updated: Dec 13, 2025

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.8K

Spine and Non-spine Bone Metastases - Current Controversies and Future Direction.

A Challapalli1, S Aziz2, V Khoo3

  • 1Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|August 5, 2020
PubMed
Summary

Advanced cancer often spreads to the bone, causing pain. This overview discusses multidisciplinary treatments like surgery, radiotherapy, and bone-modifying agents to manage bone metastases and improve patient quality of life.

Keywords:
Bone metastasesbone-modifying agentsbone-targeted radionuclidespalliative radiotherapysurgery

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.2K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.1K

Related Experiment Videos

Last Updated: Dec 13, 2025

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.8K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.2K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.1K

Area of Science:

  • Oncology
  • Orthopedics
  • Palliative Care

Background:

  • Bone metastases are a frequent complication of advanced cancers, significantly impacting patient morbidity and quality of life primarily through pain.
  • Current management necessitates a multidisciplinary approach to effectively alleviate pain and enhance quality of life.

Purpose of the Study:

  • To provide an overview of therapeutic options for managing bone metastases, focusing on palliative care strategies.
  • To review the roles of surgery, radiotherapy, bone-targeting radionuclides, and bone-modifying agents in palliation.

Main Methods:

  • Literature review focusing on surgical interventions (including minimally invasive), conventional radiotherapy for spinal and non-spinal metastases, bone-targeting radionuclides, and bone-modifying agents.
  • Presentation of clinical data and associated toxicity profiles for discussed treatments.

Main Results:

  • Various palliative treatment options exist beyond systemic anticancer therapy, including analgesics, surgery, radiotherapy, radioisotopes, and bone-modifying agents.
  • Radiotherapy is effective for localized disease, while radionuclides benefit multiple lesions. Bone-modifying agents reduce skeletal-related events.
  • Minimally invasive surgical techniques are also discussed for managing bone metastases.

Conclusions:

  • A multidisciplinary approach integrating surgery, radiotherapy, radionuclides, and bone-modifying agents is crucial for effective palliation of bone metastases.
  • These interventions aim to relieve pain, improve quality of life, and reduce skeletal-related events in cancer patients with bone involvement.